snk01,avelumab
merck,nkgen,pfizer
['snk01', 'sarcoma', 'avelumab']
 #sarcoma poster discussion session at #asco2022 abs 11517 novel approach: snk01 autologous non-genetically modified nk cell therapy tested in combination with #avelumab in refractory #sarcoma. 1 med. pfs: 11.28 wk
2 med. survival: 24.86 wk
3 no snk01 related ae reported
Independent & international experts in #Sarcoma. #MedEd communicators, keeping you up to date with research & medical news in Sarcoma. Part of https://t.co/qM8Tca8PQX